SynthesisBMC cancer2021

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.

Zohreh Maghsoomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.